Head to Head Analysis: Ramsay Health Care (OTCMKTS:RMYHY) and Progyny (NASDAQ:PGNY)

Ramsay Health Care (OTCMKTS:RMYHYGet Free Report) and Progyny (NASDAQ:PGNYGet Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Institutional and Insider Ownership

94.9% of Progyny shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Ramsay Health Care and Progyny, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ramsay Health Care 1 2 0 0 1.67
Progyny 0 4 8 0 2.67

Progyny has a consensus target price of $29.80, suggesting a potential upside of 44.03%. Given Progyny’s stronger consensus rating and higher probable upside, analysts plainly believe Progyny is more favorable than Ramsay Health Care.

Profitability

This table compares Ramsay Health Care and Progyny’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ramsay Health Care N/A N/A N/A
Progyny 4.46% 10.71% 7.27%

Volatility & Risk

Ramsay Health Care has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500. Comparatively, Progyny has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Valuation & Earnings

This table compares Ramsay Health Care and Progyny”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ramsay Health Care N/A N/A N/A N/A N/A
Progyny $1.17 billion 1.53 $54.34 million $0.63 32.84

Progyny has higher revenue and earnings than Ramsay Health Care.

Summary

Progyny beats Ramsay Health Care on 10 of the 10 factors compared between the two stocks.

About Ramsay Health Care

(Get Free Report)

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

About Progyny

(Get Free Report)

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Receive News & Ratings for Ramsay Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ramsay Health Care and related companies with MarketBeat.com's FREE daily email newsletter.